Early Detection of Prostate Cancer in Primary Care
Join this webinar with Dr Alexander Norman and Amy Rylance to explore prostate cancer risk factors, PSA blood testing, diagnostic updates, health inequalities and understand the development of the National Screening Committee (NSC) and the TRANSFORM trial. Chaired by Rhiannon Ashman and in collaboration with MIMs, the session will provide practical guidance to support informed decision-making and improve outcomes in primary care.
Early Diagnosis Webinar for Scotland
Join Dr Sam Merriel, GP and NIHR Academic Clinical Lecturer at the Centre for Primary Care and Health Services Research at the University of Manchester, and Naomi Line, Education Manager at Prostate Cancer UK for a focused webinar on enhancing early detection of prostate cancer in Scotland. Tailored for primary care professionals, this session offers insights into risk assessment, PSA testing, and addressing health disparities.
Through Mervin’s Eyes: Reflecting on Prostate Cancer Care
Dr Veronica Moshokgo and Mervin explore disparities in prostate cancer diagnosis and treatment for Black men, promoting equitable, compassionate care.
National Prostate Cancer Audit: State of the Nation Report 2025
Many men across England may not be receiving recommended combination treatment strategies (treatment intensification) for their metastatic prostate cancer. Black men and men from more socioeconomic backgrounds are less likely to receive appropriate treatment compared to White men and men from less socioeconomic backgrounds.
PSA diagnostic case studies
Dr Sam Merriel and Dr Olly Hulson cover some case studies common to Primary Care, to explore early diagnosis and diagnostic pathways through real-world scenarios.
PSA consensus recommendations and implications for practice
Dr. Sam Merriel presents PSA consensus recommendations and implications for practice.
Lived experience conversation
Meg Burgess, Specialist Nurse at Prostate Cancer UK, leads a lived experience conversation with Tony, Junior, and Patrick.
Lifetime risk of being diagnosed with, or dying from, prostate cancer by major ethnic group in England 2008–2010
The article reveals that Black men in England face significantly higher lifetime risks of prostate cancer diagnosis and mortality compared to White and Asian men, with the highest diagnosis and death rates among Black men, while mortality rates post-diagnosis are similar across ethnic groups.
The importance of real-world data in prostate cancer
Natalia Norori, Data & Evidence Manager at Prostate Cancer UK, helps us understand the importance of real- world data in prostate cancer.
Considerations for transgender and gender diverse patients with prostate cancer
Stewarts O’Callagham, CEO at OUTpatients, Alison Berner, Academic Clinical Lecturer at the Barts Cancer Institute , and Lloyd Young, patient with lived experience, share their considerations on the LGBTQI+ prostate cancer patients.